Phenytoin-associated hypersensitivity syndrome with features of dress and TEN/SJS

Cutis

Volumn 85, Issue 6, 2010, Pages 312-317

  Viera, Martha H ^a   Perez, Oliver A ^a   Patel, Jitendrakumar K ^a   Jones, Isaac ^a   Berman, Brian ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; PHENYTOIN;

ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG ERUPTION; DRUG HYPERSENSITIVITY; EOSINOPHILIA; FEMALE; HUMAN; MIDDLE AGED; PATHOLOGY; STEVENS JOHNSON SYNDROME; SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

ANTICONVULSANTS; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; EOSINOPHILIA; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; MIDDLE AGED; PHENYTOIN; STEVENS-JOHNSON SYNDROME; SYNDROME;

EID: 77955829595     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Revuz J. New advances in severe adverse drug reactions. Dermatol Clin. 2001;19:697-709.
2. Queyrel V, Catteau B, Michon-Pasturel U, et al. DRESS (drug rash with eosinophilia and systemic symptoms) syndrome after sulfasalazine and carmazepine: report of two cases [in French]. Rev Med Interne. 2001;22:582-586.
3. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg. 1996;15:250-257.
4. Claudio GA, Martin AF, de Dios Perrino S, et al. DRESS syndrome associated with nevirapine therapy. Arch Intern Med. 2001;161:2501-2502.
5. Allam JP, Paus T, Reichel C, et al. DRESS syndrome associated with carbamazepine and phenytoin. Eur J Dermatol. 2004;14:339-342.
6. Seitz CS, Pfeuffer P, Raith P, et al. Anticonvulsant hypersensitivity syndrome: cross-reactivity with tricyclic antidepressant agents. Ann Allergy Asthma Immunol. 2006;97:698-702.
7. Bosdure E, Cano A, Roquelaure B, et al. Oxcarbazepine and DRESS syndrome: a paediatric cause of acute liver failure [in French]. Arch Pediatr. 2004;11:1073-1077.
8. Michel F, Navellou JC, Ferraud D, et al. DRESS syndrome in a patient on sulfasalazine for rheumatoid arthritis. Joint Bone Spine. 2005;72:82-85.
9. Gaig P, Garcia-Ortega P, Baltasar M, et al. Drug neosensitization during anticonvulsant hypersensitivity syndrome. J Investig Allergol Clin Immunol. 2006;16:321-326.
10. Le Nouail P, Viseux V, Chaby G, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS) following imatinib therapy. Ann Dermatol Venereol. 2006;133(8-9, pt 1):686-688.
11. Bourguignon R, Piérrard-Franchimont C, Paquet P, et al.DRESS syndrome to sulfasalzine. Rev Med Liege. 2006;61:643-648.
12. Gréco M, Dupré-Goetghebeur D, Leroy JP, et al. DRESS syndrome related to Hexaquine (quinine and thiamine)[in French]. Ann Dermatol Venereol. 2006;133:354-358.
13. Jeltsch H, Bertrand F, Lazarus C, et al. Cognitive performances and locomotor activity following dentate granule cell damage in rats: role of lesion extent and type of memory tested. Neurobiol Learn Mem. 2001;76:81-105.
14. Case records of the Massachusetts General Hospital. weekly clinicopathological exercises. case 26-1996. a seven-year-old boy with fever, lymphadenopathy, hepatosplenomegaly, and prominent eosinophilia. N Engl J Med. 1996;335:577-584.
15. Descamps V, Valance A, Edlinger C, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol. 2001;137:301-304.
16. Tas S, Simonart T. Drug rash with eosinophilia and systemic symptoms (DRESS syndrome). Acta Clin Belg. 1999;54:197-200.
17. Schauer P, Salaun N, Bazin S, et al. DRESS syndrome with bilateral panuveitis, elevated intraocular pressure, and HHV-6 reactivation: a case report [in French]. J Fr Ophtalmol. 2006;29:659-664.
18. Kashef MA, Kashef S, Handjani F, et al. Hodgkin lymphoma developing in a 4.5-year-old girl with hyper-IgE syndrome. Pediatr Hematol Oncol. 2006;23:59-63.
19. Metzgeroth G, Walz C, Score J, et al. Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma. Leukemia. 2007;21:1183-1188.
20. Tefferi A, Vardiman JW. The diagnostic interface between histology and molecular tests in myeloproliferative disorders. Curr Opin Hematol. 2007;14:115-122.
21. Simon D, Braathen LR, Simon HU. Anti-interlekuin-5 therapy for eosinophilic diseases [in German]. Hautarzt. 2007;58:122, 124-127.
22. Chung AD, English JC 3rd. Cutaneous hyperpigmentation and polyglandular autoimmune syndrome type II. Cutis. 1997;59:77-80.
23. Sade K, Mysels A, Levo Y, et al. Eosinophilia: a study of 100 hospitalized patients. Eur J Intern Med. 2007;18:196-201.
24. Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology. 2003;206:353-356.
25. Zuliani E, Zwahlen H, Gilliet F, et al. Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment. Clin Nephrol. 2005;64:155-158.